Assay and method for measuring alkaline phosphatase activity in urine as an index of tissue zinc deficiency
AssigneeVision Diagnostics, Inc.
InventorJERRY W. DENNEY
Life of this patent
Estimating the term…
Abstract
A kit comprising two reagents for conducting two different Assays to measure a zinc-activated enzyme in a bodily fluid. The assay results are utilized to obtain a relative zinc-activated enzyme activity value that can be correlated to tissue zinc levels. A more specific embodiment utilizes two paired reagents for conducting an A Assay and a B Assay that measure different alkaline phosphatase (ALP) activities in a urine sample to obtain a Relative Renal Alkaline Phosphatase Activity (RRAPA) value. The RRAPA value can be correlated to zinc levels in renal tissue.
Claims23
A kit, for obtaining a Relative Renal Alkaline Phosphatase Activity (RRAPA) value for a urine sample, comprising:
- a Reagent I comprising,
- a non-reactive sub-reagent comprising zinc sulfate,
- a reactive sub-reagent comprising N-nitrophenylphosphate;
- a Reagent II comprising,
- a non-reactive sub-reagent having a composition identical to the non-reactive sub-reagent of Reagent I, without the zinc sulfate;
- and
- a reactive sub-reagent having a composition identical to the reactive sub-reagent of Reagent I,
- wherein, the results obtained from Reagent I and the results obtained with Reagent II are utilized in a RRAPA Equation to obtain the RRAPA value.
A kit, for obtaining a Relative Zinc-Activated Enzyme Activity (RZAEA) value for a zinc-activated tissue enzyme in a bodily fluid sample, comprising:
- a Reagent I comprising a composition that includes zinc for measuring the total activity of the zinc-activated enzyme in the bodily fluid sample;
- and
- a Reagent II comprising a composition that is identical to the composition of Reagent I, but without zinc, for measuring the native-activity of the zinc-activated enzyme in the bodily fluid sample.
Dependencies are inferred from the claim text.